HK1223846A1 - β-酪蛋白 和減輕或預防乳糖不耐受症狀 - Google Patents

β-酪蛋白 和減輕或預防乳糖不耐受症狀

Info

Publication number
HK1223846A1
HK1223846A1 HK16112270.8A HK16112270A HK1223846A1 HK 1223846 A1 HK1223846 A1 HK 1223846A1 HK 16112270 A HK16112270 A HK 16112270A HK 1223846 A1 HK1223846 A1 HK 1223846A1
Authority
HK
Hong Kong
Prior art keywords
casein
beta
reducing
lactose intolerance
preventing symptoms
Prior art date
Application number
HK16112270.8A
Other languages
English (en)
Inventor
John Clarke Andrew
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52280344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1223846(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of HK1223846A1 publication Critical patent/HK1223846A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
HK16112270.8A 2013-07-12 2016-10-25 β-酪蛋白 和減輕或預防乳糖不耐受症狀 HK1223846A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361845480P 2013-07-12 2013-07-12
PCT/NZ2014/000141 WO2015005804A1 (en) 2013-07-12 2014-07-10 Beta-casein a2 and reducing or preventing symptoms of lactose intolerance

Publications (1)

Publication Number Publication Date
HK1223846A1 true HK1223846A1 (zh) 2017-08-11

Family

ID=52280344

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112270.8A HK1223846A1 (zh) 2013-07-12 2016-10-25 β-酪蛋白 和減輕或預防乳糖不耐受症狀

Country Status (21)

Country Link
US (3) US20160136238A1 (zh)
EP (2) EP3542805A1 (zh)
JP (2) JP6436592B2 (zh)
KR (2) KR102367941B1 (zh)
CN (3) CN105431156A (zh)
AU (2) AU2014287862B2 (zh)
BR (1) BR112016000612B8 (zh)
CA (2) CA3214545A1 (zh)
CL (1) CL2016000064A1 (zh)
DK (1) DK3019180T3 (zh)
ES (1) ES2743194T3 (zh)
HK (1) HK1223846A1 (zh)
IL (2) IL243366B (zh)
MX (2) MX368912B (zh)
MY (2) MY172939A (zh)
NZ (2) NZ754642A (zh)
PH (2) PH12016500032A1 (zh)
RU (1) RU2671562C2 (zh)
SG (2) SG11201510707YA (zh)
WO (1) WO2015005804A1 (zh)
ZA (1) ZA201600007B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10702580B2 (en) * 2015-05-22 2020-07-07 The A2 Milk Company Limited Beta-casein A2 and antioxidant capacity
WO2017003300A1 (en) * 2015-06-29 2017-01-05 The A2 Milk Company Limited A2 beta-casein and viscosity of milk products
EP3436038B1 (en) * 2016-03-30 2021-06-23 The A2 Milk Company Limited Beta-caseins and cognitive function
AU2016424981C1 (en) * 2016-09-30 2024-10-10 The A2 Milk Company Limited Beta-caseins and gut microbiota
NL2019906B1 (en) * 2017-11-14 2019-05-20 Ausnutria Hyproca B V Composition comprising a2 b-casein and a vegetable fat mixture
WO2021003741A1 (zh) * 2019-07-11 2021-01-14 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用
CN112205476A (zh) * 2019-07-11 2021-01-12 北京三元食品股份有限公司 β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451368B1 (en) 1994-04-11 2002-09-17 New Zealand Dairy Board Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
US7094949B2 (en) * 1995-05-16 2006-08-22 A2 Corporation Limited Breeding and milking cows for milk free of β-casein A1
DK0871366T3 (da) 1995-05-16 2005-10-10 A2 Corp Ltd Födevareprodukt og fremgangsmåde til fremstilling heraf
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
CN1159984C (zh) * 1999-06-29 2004-08-04 新西兰奶制品研究所有限公司 基于奶的预防性饮食添加剂
AU9037401A (en) 2000-09-08 2002-03-22 New Zealand Dairy Board Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
US20060280802A1 (en) * 2002-10-04 2006-12-14 Campbell Julie H Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
RU2370279C2 (ru) * 2003-09-23 2009-10-20 ДСМ Ай Пи ЭССЕТС Б.В. Применение пролинспецифичных эндопротеаз для гидролиза пептидов и белков
CN1899054A (zh) * 2006-07-17 2007-01-24 颜贻谦 去糖牛奶的制作方法
CN102387715A (zh) * 2009-04-03 2012-03-21 雀巢产品技术援助有限公司 奶样饮料
IE86315B1 (en) * 2009-04-15 2013-12-04 Bopa Ireland Ltd A milk product and a process for the preparation thereof
DE102010009582A1 (de) * 2010-02-05 2011-08-11 Vitacare GmbH & Co. KG, 60318 Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz
CN103315063A (zh) * 2012-03-19 2013-09-25 基斯有限公司 可预防疾病的婴儿配方奶粉
US20170086481A1 (en) * 2014-06-03 2017-03-30 Abbott Laboratories Nutritional compositions comprising a lipophilic active ingredient

Also Published As

Publication number Publication date
IL243366B (en) 2018-11-29
CA2917492A1 (en) 2015-01-15
MY190309A (en) 2022-04-13
SG11201510707YA (en) 2016-01-28
RU2671562C2 (ru) 2018-11-02
WO2015005804A1 (en) 2015-01-15
CA2917492C (en) 2023-11-14
MX2016000308A (es) 2016-11-14
EP3019180A1 (en) 2016-05-18
ZA201600007B (en) 2017-11-29
SG10201710237PA (en) 2018-01-30
BR112016000612B1 (pt) 2021-11-03
PH12019550112A1 (en) 2020-09-14
PH12016500032B1 (en) 2016-03-28
IL261143A (en) 2018-10-31
RU2018131604A (ru) 2018-11-20
US20220175882A1 (en) 2022-06-09
AU2014287862A1 (en) 2016-02-11
CN105431156A (zh) 2016-03-23
BR112016000612B8 (pt) 2022-02-22
RU2015156804A (ru) 2017-08-17
EP3019180B1 (en) 2019-05-29
MY172939A (en) 2019-12-16
NZ754642A (en) 2022-09-30
DK3019180T3 (da) 2019-08-26
KR102291660B1 (ko) 2021-08-19
RU2018131604A3 (zh) 2022-04-19
MX2019012446A (es) 2020-02-03
PH12016500032A1 (en) 2016-03-28
EP3019180A4 (en) 2017-03-08
RU2015156804A3 (zh) 2018-05-31
JP2016523958A (ja) 2016-08-12
IL261143B (en) 2021-02-28
CA3214545A1 (en) 2015-01-15
CN110800803A (zh) 2020-02-18
US20200147173A1 (en) 2020-05-14
JP2018203753A (ja) 2018-12-27
AU2019203684B2 (en) 2021-08-05
KR20200085375A (ko) 2020-07-14
JP6990154B2 (ja) 2022-01-12
JP6436592B2 (ja) 2018-12-12
ES2743194T3 (es) 2020-02-18
CN114832092A (zh) 2022-08-02
KR20160030974A (ko) 2016-03-21
EP3542805A1 (en) 2019-09-25
US20160136238A1 (en) 2016-05-19
AU2014287862B2 (en) 2019-07-11
NZ715985A (en) 2022-09-30
CL2016000064A1 (es) 2016-12-16
KR102367941B1 (ko) 2022-02-24
BR112016000612A2 (zh) 2017-07-25
AU2019203684A1 (en) 2019-06-20
MX368912B (es) 2019-10-21

Similar Documents

Publication Publication Date Title
HK1219421A1 (zh) 激酶抑制劑的組合及其用途
PL2968100T3 (pl) Kombinacje amidotiazoli alkilowych i konserwantów
IL262302B (en) Beta-casein a2 and prevention of intestinal inflammation
IL261143B (en) Beta-casein and reduction or prevention of symptoms of lactose intolerance
HK1221721A1 (zh) 蛋白抑制性的改性的二氫喹喔啉酮類化合物和二氫吡啶並吡嗪酮類化合物
HK1224307A1 (zh) 原毒素- 變體及其使用方法
GB201514996D0 (en) Rebreather system and components
SG11201505342QA (en) Valve arrangement and method of operating the same
SG11201507389RA (en) Integration of hydro-dechlorination and hydro-regeneration
IL272609B (en) Recombinant glycoproteins and their uses
HK1220693A1 (zh) 碳水化合物改性的糖蛋白及其用途
IL240787B (en) Mimetics of apoflavon and their uses
HK1222389A1 (zh) 肺病症和其他病症的治療
RS62090B1 (sr) Cu1 soj za lečenje i/ili prevenciju hroničnog inflamatornog reumatizma
GB201308639D0 (en) Biomarkers and uses of thereof
IL227381A0 (en) A towel and a clamp
GB201309452D0 (en) Magnetic fixings and connections
GB201301698D0 (en) Towel and method of manufacturing the same
TH1601000120A (th) เบต้า-เคซีน a2 เเละการลด หรือป้องกันอาการของการเเพ้เเลคโตส
GB201301393D0 (en) Kiddibidet and pottibidet

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: MALAV SUCHIN TRIVEDI

Effective date: 20200214